Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women
Postmenopausal Osteoporosis
About this trial
This is an interventional treatment trial for Postmenopausal Osteoporosis
Eligibility Criteria
Inclusion Criteria: Postmenopausal women who did not engage in any recreational physical activity in the previous three months Low bone mineral density (BMD) at their spine and/or femoral neck met the inclusion criteria. They are in good health. body mass index (BMI) ranged from 25 to 30 kg/m2, ages ranged from 50 to 60 Exclusion Criteria: mental, neurological, Vestibular, cardiovascular, metabolic disease, musculoskeletal disorders with lower limb deformity, visual or hearing impairment undergone hormone replacement therapy. any medication that affected their balance or photosensitizing medications like aspirin, tetracycline, and Chlorothiazide
Sites / Locations
- Kasr Alainy medical school
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ultraviolet therapy group
Non Ultraviolet therapy group
35 women will undergo three weekly sessions of UV therapy in addition to routine aerobic activity and vitamin D supplements (800 IU) daily for three months
35 women will undergo three weekly sessions of routine aerobic activity and vitamin D supplements (800 IU) daily for three months